This is the authors' abstract. We don't add key points for this paper.
The diagnostic approach to patients with cytopenia has become highly challenging due to the heterogenic presentation of clonal hematopoietic stem cell disorders and accompanying degenerative disorders in the generally elderly population. A holistic approach with extensive clinical experience is required to recognize the potential interactions between the clonal condition and inflammatory-degenerative comorbidities in the elderly. This narrative review highlights the diagnostic challenges in the classification and risk stratification of patients with clonal hematopoiesis and myelodysplastic neoplasms, dysregulation of immune hemostasis and its impact on degenerative-inflammatory comorbidities of the elderly from the perspective of an experienced clinician. PEER REVIEWED ARTICLE Peer reviewers: Dr Stefani Parmentier, St. Claraspital, Basel, Switzerland; KD Dr Axel Rüfer, Cantonal Hospital Luzern, Luzern, Switzerland; One anonymous peer reviewer Submitted: January 27, 2024 CEST; Accepted after peer review: March 19, 2024 CEST
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bonadies et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: